View Post

Trials Answer Questions About Duration of Treatment in HER2+ Breast Cancer

In Clinical Trials by Barbara Jacoby

By: Angelica Welch From: oncnursingnews.com The optimal duration of treatment for patients with HER2-positive breast cancer has been called into question by recent findings from the NSABP B-52, PERSEPHONE, and APT clinical trials. Priya Rastogi, MD, senior associate medical director, NSABP Medical Affairs, associate professor of Medicine, University of Pittsburgh, shed light on the subject during a presentation she gave …

View Post

Edge Therapeutics Enters into Merger Agreement with PDS Biotechnology to Form Clinical-Stage Cancer Immunotherapy Company

In Clinical Trials by Barbara Jacoby

-Merger would create publicly-traded immuno-oncology biotechnology company developing novel products for treating early- and late-stage cancer- -Growing product pipeline utilizing Versamune®, a novel, versatile, multi-functional platform- -Phase 1/2 clinical data on lead product candidate PDS0101 suggests immunotherapeutic anti-cancer activity and favorable safety profile in early stage cervical cancer- -Combined company plans to initiate multiple Phase 2b/3 clinical trials of PDS0101 …

View Post

Puma Biotechnology Presents Results of Patient Reported Outcomes in Phase II CONTROL Trial of Neratinib in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer

In Clinical Trials by Barbara Jacoby

From: businesswire.com Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, is presenting updated results from a Phase II clinical trial of Puma’s drug neratinib at the 2018 San Antonio Breast Cancer Symposium (SABCS) that is currently taking place in San Antonio, Texas. The presentation entitled, “The impact of neratinib with or without anti-diarrheal prophylaxis on health-related quality of life in …

View Post

Israeli Company Set To Begin Testing New Radiation Cancer Therapy

In Clinical Trials by Barbara Jacoby

By: Robin Seaton Jefferson sFrom: forbes.com An Israeli medical technology company is set to begin testing its new radiation cancer therapy in leading medical centers in Italy. The Alpha DaRT (Dіffusіng Alpha-emіtters Radіatіon Therapy) device delivers high-precision alpha radiation that is released when radioactive substances decay inside the tumor and kills cancer cells while sparing the surrounding healthy tissue, the …

View Post

SWOG shares trio of studies at San Antonio breast cancer symposium

In Clinical Trials by Barbara Jacoby

From: eurekalert.org SWOG Cancer Research Network members will share the results of three studies at the San Antonio Breast Cancer Symposium, an international gathering of breast cancer physicians and researchers that starts today, with an estimated 7,500 attendees expected from more than 90 countries. SWOG is an international cancer clinical trials network funded by the National Cancer Institute (NCI), part …

View Post

Patients of African descent are being denied the benefits of cancer breakthroughs. We’re changing that

In Clinical Trials by Barbara Jacoby

By: Jennifer Dent From: statnews.com Death rates from cancer are falling and access to potentially lifesaving treatments is increasing — except among Africans and Americans of African descent. This gap must be closed. Overall, the picture for cancer looks better than it did 30 years ago. In the last two decades, death rates for cancer in the U.S. have declined …

View Post

Helen F. Graham Cancer Center & Research Institute celebrates 15 years of transformative cancer care

In Clinical Trials by Barbara Jacoby

Nationally recognized for multidisciplinary cancer treatment and top enrollment in research clinical trials Celebrating 15 years of caring for patients, the Helen F. Graham Cancer Center & Research Institute has grown to become one of the most advanced cancer centers in the country, recognized for its patient-centered care as well as a robust program of research and clinical trials. “Over …

View Post

Immunotherapy Expands Treatment Options for Metastatic Bladder Cancer

In Clinical Trials by Barbara Jacoby

By: Danielle Ternyila From: targetedonc.com Several recent updates from clinical trials are transforming the treatment landscape for urothelial carcinoma across a variety of subtypes. The use of immunotherapy, in particular, provides patients who progress after standard platinum-based chemotherapy with new hope and a plethora of options. In the metastatic setting, there have been 5 immune checkpoint inhibitors approved by the …

View Post

Grants aim to provide better cancer clinical trial access for military veterans

In Clinical Trials by Barbara Jacoby

Source: swog.org Reviewed by: James Ives, MPsych From: news-medical.net For the fourth year, SWOG Cancer Research Network and its charity, The Hope Foundation for Cancer Research, are giving military veterans better access to cancer clinical trials by providing grant support to U.S. Department of Veterans Affairs medical centers. Under the VA Integration Support Program, medical centers receive a one-time $50,000 …

View Post

New Studies Using CELLSEARCH Circulating Tumor Cell Test to be Featured at San Antonio Breast Cancer Symposium

In Clinical Trials by Barbara Jacoby

Research Adds to Growing Evidence of Clinical Utility of CTCs for the management of Metastatic Breast Cancer Patients Menarini Silicon Biosystems announced today that new data utilizing the company’s CELLSEARCH® Circulating Tumor Cell Test will be presented at the upcoming 2018 San Antonio Breast Cancer Symposium (SABCS). A total of 21 studies will be presented: 20 posters and an oral …